$SENS
Senseonics Holdings, Inc. Stock $sens

$sens Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000155837024007966 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$4.865M	$5.047M
YoY Change	17.91%	22.0%
Cost Of Revenue	$4.567M	$4.712M
YoY Change	23.13%	26.56%
Gross Profit	$298.0K	$300.0K
YoY Change	-25.5%	-25.0%
Gross Profit Margin	6.13%	5.94%
Selling, General & Admin	$8.991M	$8.129M
YoY Change	20.6%	5.33%
% of Gross Profit	3017.11%	2709.67%
Research & Development	$10.80M	$10.44M
YoY Change	-15.82%	-15.86%
% of Gross Profit	3624.16%	3479.33%
Depreciation & Amortization	$344.0K	$169.0K
YoY Change	57.8%	-28.39%
% of Gross Profit	115.44%	56.33%
Operating Expenses	$19.79M	$18.57M
YoY Change	-2.44%	-7.73%
Operating Profit	-$19.49M	-$18.23M
YoY Change	-1.89%	-7.49%
Interest Expense	$2.085M	$2.047M
YoY Change	-9.74%	-56.0%
% of Operating Profit
Other Income/Expense, Net	-$794.0K	-$645.0K
YoY Change	43.06%	-103.07%
Pretax Income	-$20.29M	-$18.88M
YoY Change	-0.67%	-1525.76%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$20.29M	-$18.88M
YoY Change	-0.67%	-1525.76%
Net Earnings / Revenue	-417.0%	-374.02%
Basic Earnings Per Share	-$0.03	-$0.03
Diluted Earnings Per Share	-$0.03	-$0.03
COMMON SHARES
Basic Shares Outstanding	530.9M	530.7M
Diluted Shares Outstanding	616.6M	614.6M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$84.63M	$98.71M
YoY Change	-32.34%	-27.74%
Cash & Equivalents	$34.85M	$90.54M
Short-Term Investments	$49.77M	$8.169M
Other Short-Term Assets
YoY Change
Inventory	$7.215M	$7.963M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$103.0M	$118.2M
YoY Change	-25.48%	-19.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.306M	$1.436M
YoY Change	257.41%	37.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$8.547M	$8.339M
YoY Change	-43.52%	-31.63%
TOTAL ASSETS
Total Short-Term Assets	$103.0M	$118.2M
Total Long-Term Assets	$8.547M	$8.339M
Total Assets	$111.6M	$126.5M
YoY Change	-27.26%	-20.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.331M	$675.0K
YoY Change	36.51%	4.49%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$33.12M	$29.82M
YoY Change	108.78%	108.86%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$6.010M	$6.114M
YoY Change	-6.21%	137.34%
Total Long-Term Liabilities	$6.010M	$6.114M
YoY Change	-6.21%	137.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.12M	$29.82M
Total Long-Term Liabilities	$6.010M	$6.114M
Total Liabilities	$73.33M	$69.90M
YoY Change	16.08%	23.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$908.4M	-$888.1M
YoY Change	9.71%	9.98%
Common Stock	$535.0K	$530.0K
YoY Change	8.52%	10.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$578.0K	$18.96M
YoY Change
Total Liabilities & Shareholders Equity	$111.6M	$126.5M
YoY Change	-27.26%	-20.2%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$20.29M	-$18.88M
YoY Change	-0.67%	-1525.76%
Depreciation, Depletion And Amortization	$344.0K	$169.0K
YoY Change	57.8%	-28.39%
Cash From Operating Activities	-$11.14M	-$20.26M
YoY Change	-38.04%	2.09%
INVESTING ACTIVITIES
Capital Expenditures	$2.092M	$316.0K
YoY Change		454.39%
Acquisitions
YoY Change
Other Investing Activities	-$41.44M	$25.70M
YoY Change	916.61%	-14.36%
Cash From Investing Activities	-$43.53M	$25.38M
YoY Change	967.93%	-15.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.018M	10.03M
YoY Change	-118.42%	-1343.37%
NET CHANGE
Cash From Operating Activities	-11.14M	-20.26M
Cash From Investing Activities	-43.53M	25.38M
Cash From Financing Activities	-1.018M	10.03M
Net Change In Cash	-55.69M	15.15M
YoY Change	236.82%	63.05%
FREE CASH FLOW
Cash From Operating Activities	-$11.14M	-$20.26M
Capital Expenditures	$2.092M	$316.0K
Free Cash Flow	-$13.23M	-$20.58M
YoY Change	-26.41%	3.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001616543
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	530364237
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	530817549
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20240331#DepositsAndOtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20240331#DepositsAndOtherAssetsNoncurrent
CY2024Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20240331#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.senseonics.com/20240331#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-37717
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Senseonics Holdings, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1210911
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20451 Seneca Meadows Parkway
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876-7005
CY2024Q1	dei	City Area Code CityAreaCode	301
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	515-7260
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	SENS
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	530886421
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90544000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75709000
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	316000
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	8169000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	33747000
CY2024Q1	us-gaap	Inventory Net InventoryNet	7963000
CY2023Q4	us-gaap	Inventory Net InventoryNet	8776000
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7434000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7266000
CY2024Q1	us-gaap	Assets Current AssetsCurrent	118177000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	130030000
CY2024Q1	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	6903000
CY2023Q4	sens	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	7006000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1436000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1184000
CY2024Q1	us-gaap	Assets Assets	126516000
CY2023Q4	us-gaap	Assets Assets	138220000
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	675000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4568000
CY2024Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	17937000
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	102000
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	29819000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17257000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	33965000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	41195000
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	102000
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6114000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6214000
CY2024Q1	us-gaap	Liabilities Liabilities	69898000
CY2023Q4	us-gaap	Liabilities Liabilities	64768000
CY2024Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	12000
CY2024Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	12000
CY2024Q1	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2023Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	37656000
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	37656000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	530817549
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	530364237
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	530000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	530000
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	906569000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	904535000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-888135000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-869258000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18962000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35796000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126516000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138220000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5047000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4137000
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4712000
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3723000
CY2024Q1	us-gaap	Gross Profit GrossProfit	335000
CY2023Q1	us-gaap	Gross Profit GrossProfit	414000
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10438000
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12405000
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8129000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7718000
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18232000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19709000
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1384000
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1108000
CY2023Q1	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
CY2024Q1	us-gaap	Interest Expense InterestExpense	2047000
CY2023Q1	us-gaap	Interest Expense InterestExpense	4652000
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	5778000
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-645000
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21033000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-18877000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	9000
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	458000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	458000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18868000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1782000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	614588546
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497473222
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	614588546
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	540532813
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2576000
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-65000
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	63542000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1781000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	458000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	64464000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	35796000
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-1000
CY2024Q1	sens	Issued Common Stock For Vested Rsus And Espp Purchase IssuedCommonStockForVestedRsusAndEsppPurchase	96000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	149000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1801000
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	11000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-18877000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18962000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-18877000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1324000
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	169000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	236000
CY2024Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	906000
CY2023Q1	sens	Amortization Of Financing Costs Discounts And Deferred Costs AmortizationOfFinancingCostsDiscountsAndDeferredCosts	3212000
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	108000
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	587000
CY2023Q1	sens	Fair Value Adjustment Derivative Liability FairValueAdjustmentDerivativeLiability	-5778000
CY2023Q1	sens	Nonoperating Gain Loss Exchanges NonoperatingGainLossExchanges	18776000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1801000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1781000
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	40000
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	-15000
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	173000
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	56000
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-744000
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	953000
CY2024Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	168000
CY2023Q1	sens	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-1136000
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-773000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	874000
CY2024Q1	sens	Increase Decrease In Deposit Assets And Other Assets IncreaseDecreaseInDepositAssetsAndOtherAssets	-20000
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3913000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	227000
CY2024Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-1416000
CY2023Q1	sens	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-267000
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-182000
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-315000
CY2024Q1	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-224000
CY2023Q1	sens	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-255000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20262000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19848000
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	316000
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	57000
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	9653000
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	25695000
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	39657000
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25379000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29947000
CY2024Q1	sens	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	-1000
CY2024Q1	sens	Proceeds From Exercise Of Stock Options Rs Us And Espp Net ProceedsFromExerciseOfStockOptionsRSUsAndEsppNet	96000
CY2023Q1	sens	Proceeds From Exercise Of Stock Options Rs Us And Espp Net ProceedsFromExerciseOfStockOptionsRSUsAndEsppNet	-65000
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15700000
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9950000
CY2023Q1	sens	Proceeds From Issuance Of Warrants Net ProceedsFromIssuanceOfWarrantsNet	14958000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10034000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-807000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15151000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9292000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	75709000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35793000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90860000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45085000
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1323000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1756000
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	22000
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	48000
CY2023Q1	sens	Issuance Of Warrant In Exchange For Phc Notes IssuanceOfWarrantInExchangeForPhcNotes	48550000
CY2024Q1	sens	Issuance Of Warrants For Loan And Security Agreement IssuanceOfWarrantsForLoanAndSecurityAgreement	149000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-60400000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	142100000
CY2024Q1	us-gaap	Gross Profit GrossProfit	300000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-888100000
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	98700000
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, fair value of investments, derivative assets and liabilities, obsolete inventory, warranty obligations, variable consideration related to revenue, allowance for credit losses, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
CY2024Q1	sens	Number Of Geographical Markets NumberOfGeographicalMarkets	2
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5047000
CY2024Q1	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4137000
CY2023Q1	sens	Revenue By Geographical Region Percentage RevenueByGeographicalRegionPercentage	1.000
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1300000
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1500000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-18877000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1324000
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	-2293000
CY2024Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-18877000
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-969000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	614588546
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497473222
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2905016
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	39211358
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	943217
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	614588546
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	540532813
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2160000
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4602000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5332000
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	77850384
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47283899
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	8171000
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	8169000
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	33758000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	12000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	33747000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	8171000
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	8169000
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	8171000
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8169000
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2092000
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1269000
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1284000
CY2024Q1	us-gaap	Inventory Net InventoryNet	7963000
CY2023Q4	us-gaap	Inventory Net InventoryNet	8776000
CY2024Q1	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	3891000
CY2023Q4	sens	Prepaid Contract Manufacturing Current PrepaidContractManufacturingCurrent	4244000
CY2024Q1	sens	Tax Credits Receivable TaxCreditsReceivable	1793000
CY2023Q4	sens	Tax Credits Receivable TaxCreditsReceivable	1793000
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	745000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	73000
CY2024Q1	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	461000
CY2023Q4	sens	Prepaid Clinical And Preclinical Costs PrepaidClinicalAndPreclinicalCosts	343000
CY2024Q1	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	202000
CY2023Q4	sens	Prepaid Information Technology And Software Costs Current PrepaidInformationTechnologyAndSoftwareCostsCurrent	242000
CY2024Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	117000
CY2023Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	20000
CY2024Q1	us-gaap	Prepaid Rent PrepaidRent	96000
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	122000
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	89000
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	272000
CY2024Q1	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	38000
CY2023Q4	sens	Prepaid Accounting And Audit PrepaidAccountingAndAudit	61000
CY2023Q4	sens	Research And Development ResearchAndDevelopment	95000
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1000
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7434000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7266000
CY2024Q1	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	4213000
CY2023Q4	sens	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	3846000
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2123000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	673000
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1438000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1457000
CY2024Q1	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	1399000
CY2023Q4	sens	Accrued Contract Manufacturing Costs Current AccruedContractManufacturingCostsCurrent	4799000
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	530000
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	301000
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	521000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	704000
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	485000
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	514000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	383000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368000
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27000
CY2024Q1	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	11105000
CY2023Q4	sens	Accrued Liabilities And Other Liabilities Including Related Party Current AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent	12689000
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5097000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5180000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	383000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6114000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6214000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6497000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6582000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	688000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	939000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	967000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	996000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1026000
CY2024Q1	sens	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	4908000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9524000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3027000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6497000
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085
CY2024Q1	sens	Product Warranty Term ProductWarrantyTerm	P1Y
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	500000
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	514000
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	781000
CY2024Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	66000
CY2023	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	242000
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	95000
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	509000
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	485000
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	514000
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1141000
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	880000
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	26000
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2047000
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1441000
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3097000
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	114000
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4652000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	20399000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	12996000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	24437000
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	57832000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-007966-index-headers.html	Edgar Link	pending
0001558370-24-007966-index.html	Edgar Link	pending
0001558370-24-007966.txt	Edgar Link	pending
0001558370-24-007966-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sens-20240331.xsd	Edgar Link	pending
sens-20240331x10q.htm	Edgar Link	pending
sens-20240331xex31d1.htm	Edgar Link	pending
sens-20240331xex31d2.htm	Edgar Link	pending
sens-20240331xex32d1.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sens-20240331_cal.xml	Edgar Link	unprocessable
sens-20240331_lab.xml	Edgar Link	unprocessable
sens-20240331_pre.xml	Edgar Link	unprocessable
sens-20240331_def.xml	Edgar Link	unprocessable
sens-20240331x10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SENS
Senseonics Holdings, Inc. Stock $sens

2024 Q2 Form 10-Q Financial Statement

#000155837024007966 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS Senseonics Holdings, Inc. Stock $sens

2024 Q2 Form 10-Q Financial Statement

#000155837024007966 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SENS
Senseonics Holdings, Inc. Stock $sens